Asensus Surgical, Inc.Asensus Surgical, Inc.Asensus Surgical, Inc.

Asensus Surgical, Inc.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪70.81 M‬USD
‪−78.43 M‬USD
‪8.58 M‬USD
‪266.82 M‬
Beta (1Y)

About Asensus Surgical, Inc.

Anthony Fernando
Employees (FY)
Asensus Surgical, Inc. is a medical device company, which digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. It enables the use of advanced capabilities like augmented intelligence, connectivity and robotics in laparoscopy, and addresses the current clinical, cognitive, and economic shortcomings in surgery. The Senhance Surgical System features a machine vision system for use in robotic surgery, which is powered by the new Intelligent Surgical Unit (ISU) that enables augmented intelligence in surgery and brings the benefits of digital laparoscopy to patients around the world while staying true to the principles of value-based healthcare. The company was founded by William N. Starling on August 19, 1988 and is headquartered in Durham, NC.
Revenue to profit conversion
Debt level and coverage

See all ideas 

Summarizing what the indicators are suggesting.
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of ASXC is 0.2600 USD — it has decreased by 0.57% in the past 24 hours. Watch Asensus Surgical, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on AMEX exchange Asensus Surgical, Inc. stocks are traded under the ticker ASXC.
ASXC stock has fallen by 3.70% compared to the previous week, the month change is a 2.40% fall, over the last year Asensus Surgical, Inc. has showed a 54.39% decrease.
We've gathered analysts' opinions on Asensus Surgical, Inc. future price: according to them, ASXC price has a max estimate of 0.35 USD and a min estimate of 0.35 USD. Watch ASXC chart and read a more detailed Asensus Surgical, Inc. stock forecast: see what analysts think of Asensus Surgical, Inc. and suggest that you do with its stocks.
ASXC reached its all-time high on Jun 13, 1996 with the price of 26162.5000 USD, and its all-time low was 0.2040 USD and was reached on Oct 30, 2023. View more price dynamics on ASXC chart.
See other stocks reaching their highest and lowest prices.
ASXC stock is 9.59% volatile and has beta coefficient of 0.98. Track Asensus Surgical, Inc. stock price on the chart and check out the list of the most volatile stocks — is Asensus Surgical, Inc. there?
Today Asensus Surgical, Inc. has the market capitalization of ‪70.81 M‬, it has decreased by 3.60% over the last week.
Yes, you can track Asensus Surgical, Inc. financials in yearly and quarterly reports right on TradingView.
Asensus Surgical, Inc. is going to release the next earnings report on Aug 7, 2024. Keep track of upcoming events with our Earnings Calendar.
ASXC earnings for the last quarter are −0.07 USD per share, whereas the estimation was −0.05 USD resulting in a −40.00% surprise. The estimated earnings for the next quarter are −0.06 USD per share. See more details about Asensus Surgical, Inc. earnings.
Asensus Surgical, Inc. revenue for the last quarter amounts to ‪1.12 M‬ USD despite the estimated figure of ‪1.20 M‬ USD. In the next quarter revenue is expected to reach ‪1.25 M‬ USD.
ASXC net income for the last quarter is ‪−22.50 M‬ USD, while the quarter before that showed ‪−17.24 M‬ USD of net income which accounts for −30.53% change. Track more Asensus Surgical, Inc. financial stats to get the full picture.
No, ASXC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 20, 2024, the company has 209.00 employees. See our rating of the largest employees — is Asensus Surgical, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Asensus Surgical, Inc. EBITDA is ‪−70.28 M‬ USD, and current EBITDA margin is −867.45%. See more stats in Asensus Surgical, Inc. financial statements.
Like other stocks, ASXC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Asensus Surgical, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Asensus Surgical, Inc. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Asensus Surgical, Inc. stock shows the sell signal. See more of Asensus Surgical, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.